Luteolin Inhibits Breast Cancer Stemness and Enhances Chemosensitivity through the Nrf2-Mediated Pathway
Cancer stem cells (CSCs) are subpopulations of tumor masses with unique abilities in self-renewal, stemness maintenance, drug resistance, and the promotion of cancer recurrence. Recent studies have suggested that breast CSCs play essential roles in chemoresistance. Therefore, new agents that selecti...
Guardado en:
Autores principales: | Kuen-Jang Tsai, Hsin-Yi Tsai, Chin-Chuan Tsai, Tai-Yu Chen, Tsung-Hua Hsieh, Chun-Lin Chen, Lulekiwe Mbuyisa, Yaw-Bin Huang, Ming-Wei Lin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2613cc7450ad4f43a9ab4a40100bedae |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
MKL1 is a key biomarker correlated with immune infiltrates and chemosensitivity in breast cancer
por: Yijia Hua, et al.
Publicado: (2021) -
Mechanism of metastasis suppression by luteolin in breast cancer
por: Cook MT
Publicado: (2018) -
Luteolin inhibits lung metastasis, cell migration, and viability of triple-negative breast cancer cells
por: Cook MT, et al.
Publicado: (2016) -
Effects of neuromuscular blocking agents on central respiratory chemosensitivity in newborn rats
por: SAKURABA,SHIGEKI, et al.
Publicado: (2005) -
Delivery luteolin with folacin-modified nanoparticle for glioma therapy
por: Wu C, et al.
Publicado: (2019)